GlobeImmune, Inc., a biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platforms. The company's product candidate includes GS-4774, which is in Phase 2 trials for the treatment of patients with chronically infected...
7 insider purchases on record · latest filing 2014-07-09.
Insiders have also filed 79 sale transactions at GBIM.